Therefore, in the context of cancer, inhibiting the “normal” HSP90 function is beneficial; however, the consequent activation of the HSF1‐mediated transcriptional response feeds these oncogenic protein helpers (i.e., HSP90 and HSP70) into the same system. Here, HSP90AB1 is linked to cancer.